NCT03829969View on ClinicalTrials.gov

Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

514

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

March 22, 2021

Study Completion Date

September 30, 2023

Conditions
Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy
Interventions
BIOLOGICAL

Toripalimab

TORIPALIMAB INJECTION(JS001 ) combine with chemotherapy or placebo combine with chemotherapy

Trial Locations (1)

510060

Sun Yat-Sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Shanghai Junshi Bioscience Co., Ltd.

OTHER

NCT03829969 - Toripalimab or Placebo With Paclitaxel and Cisplatin in Esophageal Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter